SCHEMBL1207407

SCHEMBL1207407

CC1CO[C]=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428106 1.00
SCHEMBL2038093 0.65
SCHEMBL2039338 0.65
Propylene Oxide SCHEMBL7573207 0.54 CHRM2 (0.38)
SCHEMBL399751 0.52
SCHEMBL973275 0.52
SCHEMBL1150258 0.52
Propylene Oxide SCHEMBL10601297 0.51
SCHEMBL2872031 0.49
Propylene Oxide SCHEMBL1686468 0.49

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436930-B1 FOR TREATMENT OF INFECTIONS BY CANDIDA ALBICANS BRISTOL-MYERS SQUIBB COMPANY 2002-08-20 US claimed
US-20020035073-A1 Novel thio derivatives of sordarin as antifungal agents BRISTOL-MYERS SQUIBB COMPANY 2002-03-21 US claimed
WO-2002022567-A1 NOVEL THIO DERIVATIVES OF SORDARIN AS ANTIFUNGAL AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-03-21 WO claimed
EP-0830349-B1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS DU PONT PHARM CO (US) 2000-03-22 EP claimed
EP-0837855-A4 METHOD FOR PREPARING N-MONOSUBSTITUTED AND N,N'-DISUBSTITUTED UNSYMMETRICAL CYCLIC UREAS DU PONT MERCK PHARMA (US) 1998-09-02 EP claimed
EP-0837855-A1 METHOD FOR PREPARING N-MONOSUBSTITUTED AND N,N'-DISUBSTITUTED UNSYMMETRICAL CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-29 EP claimed
EP-0830349-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-03-25 EP claimed
WO-1996040652-A1 METHOD FOR PREPARING N-MONOSUBSTITUTED AND N,N'-DISUBSTITUTED UNSYMMETRICAL CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-19 WO claimed
WO-1996039393-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-12 WO claimed
US-5532357-A Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-07-02 US claimed
US-RE48622-E1 Therapeutically active pyrazolo-pyrimidine derivatives UCB Biopharma SRL (BE) 2021-07-06 US disclosed
US-20180298009-A1 Fused Pyrazole Derivatives As Kinase Inhibitors UCB BIOPHARMA SPRL (BE) 2018-10-18 US disclosed
US-10087180-B2 Pyrazolo-pyridine derivatives as kinase inhibitors UCB BIOPHARMA SPRL (BE) 2018-10-02 US disclosed
US-20180273525-A1 Fused Pyridine Derivatives As Kinase Inhibitors UCB BIOPHARMA SPRL (BE) 2018-09-27 US disclosed
EP-3356365-A1 FUSED PYRIDINE DERIVATIVES AS KINASE INHIBITORS UCB Biopharma SPRL (BE) 2018-08-08 EP disclosed
US-4797148-A HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1989-01-10 US disclosed
EP-0224823-A2 Quinoline derivatives and their use in combating unwanted plant growth BASF Aktiengesellschaft (DE) 1987-06-10 EP disclosed
US-4350519-A SELECTIVE ACTION, PRE- AND POSTEMERGENCE CIBA-GEIGY CORPORATION (US) 1982-09-21 US disclosed
US-3979369-A DIENE POLYMER MONSANTO COMPANY (US) 1976-09-07 US disclosed
US-3974170-A SULFONATES, SULFINATES MONSANTO COMPANY (US) 1976-08-10 US disclosed